CYP2C19 polymorphism and risk for essential tremor

被引：0
|
作者：
Alonso-Navarro, H.
Martinez, C.
Garcia-Martin, E.
Benito-Leon, J.
Garcia-Ferrer, I.
Vazquez-Torres, P.
Puertas, I.
Lopez-Alburquerqe, T.
Agundez, J. A. G.
Jimenez-Jimenez, F. J.
机构：
[1] Univ Alcala de Henares, Hosp Principe Asturias, Madrid, Spain
[2] Univ Extremadura, Dept Pharmacol & Psychiat, Badajoz, Spain
[3] Univ Extremadura, Dept Biochem & Mol Biol, Badajoz, Spain
[4] Hosp Mostoles, Neurol Sect, Mostoles, Spain
[5] Univ Hosp Salamanca, Neurol Sect, Salamanca, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [41] Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population
    Hanioka, N.
    Tsuneto, Y.
    Saito, Y.
    Sumada, T.
    Maekawa, K.
    Saito, K.
    Sawada, J.
    Narimatsu, S.
    XENOBIOTICA, 2007, 37 (04) : 342 - 355
  • [42] Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro:: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism
    Shon, JH
    Yoon, YR
    Kim, MJ
    Kim, KA
    Lim, YC
    Liu, KH
    Shin, DH
    Lee, CH
    Cha, IJ
    Shin, JG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 552 - 563
  • [43] The impact of CYP2C19 gene polymorphism on the antiplatelet effect of clopidogrel and ticlopidine; the efficacy of ticlopidine on the non-responders of clopidogrel with CYP2C19 gene polymorphism
    Ishiguro, H.
    Asai, T.
    Umemoto, N.
    Sumida, A.
    Shimizu, K.
    Murohara, T.
    Maeda, A.
    Ando, H.
    Fujimura, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 968 - 968
  • [44] Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles
    Kim, K. -A.
    Song, W. -K.
    Kim, K. -R.
    Park, J. -Y.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (06) : 697 - 703
  • [45] Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication
    Ozdil, Burhan
    Akkiz, Hikmet
    Bayram, Suleyman
    Bekar, Aynur
    Akgollu, Ersin
    Sandikci, Macit
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2010, 21 (01): : 23 - 28
  • [46] Association between CYP2C19 genotype and proguanil oxidative polymorphism
    Coller, JK
    Somogyi, AA
    Bochner, F
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (06) : 659 - 660
  • [47] Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism
    Hui-Yan Shi
    Jin Yan
    Wen-Hui Zhu
    Guo-Ping Yang
    Zhi-Rong Tan
    Wei-Hua Wu
    Gan Zhou
    Xiao-Ping Chen
    Dong-Sheng Ouyang
    European Journal of Clinical Pharmacology, 2010, 66 : 1131 - 1136
  • [48] Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism
    Lutz, M
    Schwab, M
    Griese, EU
    Marx, C
    Müller-Oerlinghausen, B
    Schönhöfer, PS
    Meisner, C
    Gleiter, CH
    Eichelbaum, M
    Mörike, K
    PHARMACOGENETICS, 2002, 12 (01): : 73 - 75
  • [49] CYP2C19 polymorphism affects personality traits of Japanese females
    Ishii, Genki
    Suzuki, Akihito
    Oshino, Shingo
    Shiraishi, Hiroaki
    Otani, Koichi
    NEUROSCIENCE LETTERS, 2007, 411 (01) : 77 - 80
  • [50] Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism
    Shi, Hui-Yan
    Yan, Jin
    Zhu, Wen-Hui
    Yang, Guo-Ping
    Tan, Zhi-Rong
    Wu, Wei-Hua
    Zhou, Gan
    Chen, Xiao-Ping
    Ouyang, Dong-Sheng
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (11) : 1131 - 1136
12345